The inconsistencies in India’s Covid-19 vaccine approval system ...Middle East

Economy by : (Quartz) -
India’s subject expert committee (SEC) on Covid-19 vaccines has been mercurial in its approval processes.On Feb. 24, India’s drug authority refused to authorise Sputnik V, the vaccine developed in Russia and under a bridging trial in the country, for emergency use. The government authority has asked Dr Reddy’s, the Indian pharmaceutical company facilitating the trials in the country, to supply data on immunogenicity, according to a source-based report in The Economic Times newspaper.Safety and immunogenicity data are collected during the first two phases of human trials, and efficacy data are generated once phase 3 trials end. The vaccine committee bases its approval decisions based on the d

Hence then, the article about the inconsistencies in india s covid 19 vaccine approval system was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( The inconsistencies in India’s Covid-19 vaccine approval system )

Last updated :

Also on site :

Most Viewed Economy
جديد الاخبار